Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Product containing trastuzumab (medicinal product) |
Is a |
Murine-human monoclonal IgG antibody (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing trastuzumab (medicinal product) |
Is a |
agent antinéoplasique |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing trastuzumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing trastuzumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Biological agent |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing trastuzumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Trastuzumab |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing trastuzumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Monoclonal antibody |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing trastuzumab (medicinal product) |
Is a |
Product containing monoclonal antibody (product) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing trastuzumab (medicinal product) |
Is a |
Immunomodulator-containing product |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing trastuzumab (medicinal product) |
Is a |
Product containing enzyme inhibitor (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing trastuzumab (medicinal product) |
Is a |
Protein-tyrosine kinase inhibitor-containing product |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing trastuzumab (medicinal product) |
Plays role |
Antineoplastic therapeutic role |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing trastuzumab (medicinal product) |
Is a |
Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing trastuzumab (medicinal product) |
Is a |
Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing trastuzumab (medicinal product) |
Is a |
Protein kinase inhibitor-containing product |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|